Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AstraZeneca, Ionis Win A Key US FDA Approval With Wainua For ATTR Polyneuropathy
Drug Launches In January Under Co-Commercialization Deal
Dec 22 2023
•
By
Mandy Jackson
Wainua is the first patient-administered drug for ATTR-PN • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip